HOME >> BIOLOGY >> NEWS
Rethinking anti-oxidants

A leading researcher at the University of New South Wales (UNSW) points out that there is little convincing evidence that dietary antioxidant supplements such as vitamin E prevent heart disease, despite claims to the contrary.

Instead there has been a surprise finding, which relates to a synthetic antioxidant, the drug Probucol, which is no longer prescribed in Australia.

"There has been a lot of hype which suggested that antioxidant vitamin supplements had a beneficial outcome for cardiovascular disease. There is no good scientific support for the notion that people who suffer from atherosclerosis, or who are at elevated risk of heart disease, gain benefit by supplements of vitamin E," said Professor Roland Stocker, from the Centre for Vascular Research at UNSW, who will present his research at the ISTH Congress in Sydney today.

Stocker reported, "Our research is now leading towards the development of a new drug, based on Probucol. Probucol was previously used to reduce so-called "bad" cholesterol for those with heart disease, but it also had side effects, such as reducing "good" cholesterol and possibly inducing an irregular heartbeat.

This new compound, which has a similar structure to probucol, is very effective in protecting against atherosclerosis (the principal cause of coronary heart disease) in animal models but doesn't have the same side effects"

He went onto say, "We have shown that this novel probucol-analog induces a pathway in the vessel wall which is both anti-oxidative and anti-inflammatory. The early signs are that it provides strong protection for blood vessel walls. We are now progressing these studies further with a pharmaceutical company."

"This compound potentially represents a new approach for treating people with or at risk of heart disease at the source of the problem in the vessel wall. Vitamin E is not depleted or deficient in people with heart disease. It is in my view, a nave ide
'"/>

Contact: Sarah Meachem
Sarah.Meachem@phimr.monash.edu.au
61-412-640-774
Research Australia
9-Aug-2005


Page: 1 2

Related biology news :

1. Rethinking new therapies for Crohns disease at U.Va.

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2020)... ... ... A team of researchers at the Icahn School of Medicine at Mount Sinai, ... causes coronavirus disease (COVID-19). This antibody is intended to block the virus from entering ... efforts are being led by Mone Zaidi, MD, PhD, MACP, Director of the Mount ...
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... ... digital transformation and innovation in technology and compliance, announces a new managed service ... best-in-class trio of alliances – Box, ComplianceQuest, and USDM Life Sciences (USDM) – ...
(Date:4/16/2020)... ... April 15, 2020 , ... With ... to create a vaccine to this novel virus. In an effort to accelerate ... Complex Systems (LRC), is announcing the development of Sample.Exchange, a web-based platform ...
Breaking Biology News(10 mins):
(Date:4/7/2020)... ... April 06, 2020 , ... Gateway Genomics , leading developer of ... SneakPeek Early Gender DNA Tests sold in March, just months after attaining the ... ecommerce product, where a mom could order her kit online, collect a DNA sample ...
(Date:4/1/2020)... AUSTIN, Texas (PRWEB) , ... March 30, 2020 ... ... MD (APMD) and telehealth developer Reliant Immune Diagnostics (RID), formed earlier this year ... the COVID-19 pandemic by creating in-home tests for COVID-19. Company officials are currently?awaiting ...
(Date:4/1/2020)... , ... March 31, 2020 , ... ... (P2) announce the signing of a Joint Development Agreement that builds on ... Research, Inc. is a global leader in the supply of high-quality insect pheromones ...
(Date:3/19/2020)... FREDERICK, Md. (PRWEB) , ... ... ... announces a clinical supply and manufacturing collaboration agreement with pioneering gene circuit ... gene-modified cell therapies for ovarian cancer and other solid tumor indications. The ...
Breaking Biology Technology:
Cached News: